AU2009228322B2 - High expression Zymomonas promoters - Google Patents
High expression Zymomonas promoters Download PDFInfo
- Publication number
- AU2009228322B2 AU2009228322B2 AU2009228322A AU2009228322A AU2009228322B2 AU 2009228322 B2 AU2009228322 B2 AU 2009228322B2 AU 2009228322 A AU2009228322 A AU 2009228322A AU 2009228322 A AU2009228322 A AU 2009228322A AU 2009228322 B2 AU2009228322 B2 AU 2009228322B2
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- acid molecule
- xylose
- promoter
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 241000588901 Zymomonas Species 0.000 title claims description 15
- 230000014509 gene expression Effects 0.000 title description 78
- 108090000623 proteins and genes Proteins 0.000 claims description 114
- 239000013612 plasmid Substances 0.000 claims description 103
- 241000588902 Zymomonas mobilis Species 0.000 claims description 64
- 230000000694 effects Effects 0.000 claims description 60
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims description 46
- 150000007523 nucleic acids Chemical class 0.000 claims description 46
- 108020004707 nucleic acids Proteins 0.000 claims description 39
- 102000039446 nucleic acids Human genes 0.000 claims description 39
- 239000013598 vector Substances 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 29
- 102000004169 proteins and genes Human genes 0.000 claims description 25
- 230000001580 bacterial effect Effects 0.000 claims description 15
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 14
- 238000006467 substitution reaction Methods 0.000 claims description 12
- 241001464778 Zymobacter Species 0.000 claims description 8
- 230000001105 regulatory effect Effects 0.000 claims description 8
- 230000037429 base substitution Effects 0.000 claims description 4
- 230000003362 replicative effect Effects 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- 108020005544 Antisense RNA Proteins 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 108090000994 Catalytic RNA Proteins 0.000 claims description 2
- 102000053642 Catalytic RNA Human genes 0.000 claims description 2
- 239000003184 complementary RNA Substances 0.000 claims description 2
- 230000002452 interceptive effect Effects 0.000 claims description 2
- 108091092562 ribozyme Proteins 0.000 claims description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 164
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 83
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 82
- 239000012634 fragment Substances 0.000 description 77
- 108020004414 DNA Proteins 0.000 description 76
- 210000004027 cell Anatomy 0.000 description 56
- 108700040099 Xylose isomerases Proteins 0.000 description 51
- 230000012010 growth Effects 0.000 description 48
- 108020005610 ribose 5-phosphate isomerase Proteins 0.000 description 43
- 102000007382 Ribose-5-phosphate isomerase Human genes 0.000 description 41
- 239000002773 nucleotide Substances 0.000 description 39
- 125000003729 nucleotide group Chemical group 0.000 description 39
- 241000588724 Escherichia coli Species 0.000 description 35
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 35
- 230000035772 mutation Effects 0.000 description 33
- 108091026890 Coding region Proteins 0.000 description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- 108091028043 Nucleic acid sequence Proteins 0.000 description 28
- 229960000268 spectinomycin Drugs 0.000 description 28
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 28
- 102000004190 Enzymes Human genes 0.000 description 26
- 108090000790 Enzymes Proteins 0.000 description 26
- LXJXRIRHZLFYRP-UHFFFAOYSA-N glyceraldehyde 3-phosphate Chemical compound O=CC(O)COP(O)(O)=O LXJXRIRHZLFYRP-UHFFFAOYSA-N 0.000 description 26
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 24
- 102100029089 Xylulose kinase Human genes 0.000 description 24
- 239000008103 glucose Substances 0.000 description 24
- 108091022915 xylulokinase Proteins 0.000 description 24
- 238000010276 construction Methods 0.000 description 22
- 235000018102 proteins Nutrition 0.000 description 22
- 102000014701 Transketolase Human genes 0.000 description 20
- 108010043652 Transketolase Proteins 0.000 description 20
- 230000009466 transformation Effects 0.000 description 19
- 230000006978 adaptation Effects 0.000 description 18
- 230000008859 change Effects 0.000 description 18
- 230000010354 integration Effects 0.000 description 17
- 239000002609 medium Substances 0.000 description 17
- 238000012546 transfer Methods 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 239000000047 product Substances 0.000 description 15
- 230000003321 amplification Effects 0.000 description 13
- 238000003556 assay Methods 0.000 description 13
- 238000003199 nucleic acid amplification method Methods 0.000 description 13
- 239000007320 rich medium Substances 0.000 description 13
- 229920001817 Agar Polymers 0.000 description 12
- 239000008272 agar Substances 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 12
- 102100028601 Transaldolase Human genes 0.000 description 11
- 108020004530 Transaldolase Proteins 0.000 description 11
- 101150067314 aadA gene Proteins 0.000 description 11
- 238000010367 cloning Methods 0.000 description 11
- 230000017105 transposition Effects 0.000 description 11
- 230000008569 process Effects 0.000 description 10
- 108700026244 Open Reading Frames Proteins 0.000 description 9
- 108091081024 Start codon Proteins 0.000 description 9
- 238000000246 agarose gel electrophoresis Methods 0.000 description 9
- 229940041514 candida albicans extract Drugs 0.000 description 9
- 238000004520 electroporation Methods 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 238000000855 fermentation Methods 0.000 description 9
- 230000004151 fermentation Effects 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000003550 marker Substances 0.000 description 9
- 239000012138 yeast extract Substances 0.000 description 9
- 239000013613 expression plasmid Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 7
- 238000005520 cutting process Methods 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 238000007429 general method Methods 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 108020004705 Codon Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000006137 Luria-Bertani broth Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 229960005091 chloramphenicol Drugs 0.000 description 6
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 6
- 238000012217 deletion Methods 0.000 description 6
- 230000037430 deletion Effects 0.000 description 6
- 239000013604 expression vector Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 230000004127 xylose metabolism Effects 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 5
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 108010020764 Transposases Proteins 0.000 description 5
- 102000008579 Transposases Human genes 0.000 description 5
- 229960000723 ampicillin Drugs 0.000 description 5
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 5
- 239000008188 pellet Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000000527 sonication Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 230000014621 translational initiation Effects 0.000 description 5
- 239000012137 tryptone Substances 0.000 description 5
- NGHMDNPXVRFFGS-IUYQGCFVSA-N D-erythrose 4-phosphate Chemical compound O=C[C@H](O)[C@H](O)COP(O)(O)=O NGHMDNPXVRFFGS-IUYQGCFVSA-N 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 108010051219 Cre recombinase Proteins 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 238000012300 Sequence Analysis Methods 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- 238000007824 enzymatic assay Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 239000012723 sample buffer Substances 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 239000006152 selective media Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- HHDDCCUIIUWNGJ-UHFFFAOYSA-N 3-hydroxypyruvic acid Chemical compound OCC(=O)C(O)=O HHDDCCUIIUWNGJ-UHFFFAOYSA-N 0.000 description 2
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 2
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- FNZLKVNUWIIPSJ-RFZPGFLSSA-N D-xylulose 5-phosphate Chemical compound OCC(=O)[C@@H](O)[C@H](O)COP(O)(O)=O FNZLKVNUWIIPSJ-RFZPGFLSSA-N 0.000 description 2
- 241001302160 Escherichia coli str. K-12 substr. DH10B Species 0.000 description 2
- 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 2
- 102000005731 Glucose-6-phosphate isomerase Human genes 0.000 description 2
- 108010009512 Glucose-fructose oxidoreductase Proteins 0.000 description 2
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 2
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 2
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 description 2
- 102000004195 Isomerases Human genes 0.000 description 2
- 108090000769 Isomerases Proteins 0.000 description 2
- 108010009384 L-Iditol 2-Dehydrogenase Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 102100026974 Sorbitol dehydrogenase Human genes 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 2
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 2
- 241001464780 Zymobacter palmae Species 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004108 pentose phosphate pathway Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 2
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000013605 shuttle vector Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 235000008170 thiamine pyrophosphate Nutrition 0.000 description 2
- 239000011678 thiamine pyrophosphate Substances 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- -1 useful products Chemical compound 0.000 description 2
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 101150096316 5 gene Proteins 0.000 description 1
- 238000000035 BCA protein assay Methods 0.000 description 1
- 101000583086 Bunodosoma granuliferum Delta-actitoxin-Bgr2b Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 108091029795 Intergenic region Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 239000011542 SDS running buffer Substances 0.000 description 1
- 101100072644 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) INO2 gene Proteins 0.000 description 1
- 101100454372 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) LCB2 gene Proteins 0.000 description 1
- 101100489624 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RTS1 gene Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 108010012306 Tn5 transposase Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-VPENINKCSA-N aldehydo-D-xylose Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-VPENINKCSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 101150073130 ampR gene Proteins 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000025938 carbohydrate utilization Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000459 effect on growth Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000002803 fossil fuel Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- GSXOAOHZAIYLCY-HSUXUTPPSA-N keto-D-fructose 6-phosphate Chemical compound OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O GSXOAOHZAIYLCY-HSUXUTPPSA-N 0.000 description 1
- 239000012978 lignocellulosic material Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 229940054192 micro-guard Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000019525 primary metabolic process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 101150066870 recG gene Proteins 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- AIDBEARHLBRLMO-UHFFFAOYSA-M sodium;dodecyl sulfate;2-morpholin-4-ylethanesulfonic acid Chemical compound [Na+].OS(=O)(=O)CCN1CCOCC1.CCCCCCCCCCCCOS([O-])(=O)=O AIDBEARHLBRLMO-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229960002363 thiamine pyrophosphate Drugs 0.000 description 1
- AYEKOFBPNLCAJY-UHFFFAOYSA-O thiamine pyrophosphate Chemical compound CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N AYEKOFBPNLCAJY-UHFFFAOYSA-O 0.000 description 1
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3987108P | 2008-03-27 | 2008-03-27 | |
| US61/039,871 | 2008-03-27 | ||
| PCT/US2009/038158 WO2009120730A2 (en) | 2008-03-27 | 2009-03-25 | High expression zymomonas promoters |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2009228322A1 AU2009228322A1 (en) | 2009-10-01 |
| AU2009228322B2 true AU2009228322B2 (en) | 2013-09-26 |
Family
ID=41010370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2009228322A Ceased AU2009228322B2 (en) | 2008-03-27 | 2009-03-25 | High expression Zymomonas promoters |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7989206B2 (https=) |
| EP (1) | EP2271755B1 (https=) |
| JP (1) | JP5444323B2 (https=) |
| CN (1) | CN101981184B (https=) |
| AU (1) | AU2009228322B2 (https=) |
| BR (1) | BRPI0906241B8 (https=) |
| CA (1) | CA2716590C (https=) |
| ES (1) | ES2627671T3 (https=) |
| PL (1) | PL2271755T3 (https=) |
| WO (1) | WO2009120730A2 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8247208B2 (en) | 2008-12-22 | 2012-08-21 | Alliance For Sustainable Energy Llc | Zymomonas with improved xylose utilization in stress conditions |
| US8647850B2 (en) | 2009-12-23 | 2014-02-11 | E I Du Pont De Nemours And Company | Process for simultaneous saccharification and fermentation for production of ethanol |
| US8623623B2 (en) | 2010-06-29 | 2014-01-07 | E I Du Pont De Nemours And Company | Xylose utilization in recombinant Zymomonas |
| US8679822B2 (en) | 2010-06-29 | 2014-03-25 | E I Du Pont De Nemours And Company | Xylose utilization in recombinant zymomonas |
| US8476048B2 (en) | 2010-12-17 | 2013-07-02 | E I Du Pont De Nemours And Company | Xylose utilizing zymomonas mobilis with improved ethanol production in biomass hydrolysate medium |
| US8765426B2 (en) | 2011-04-07 | 2014-07-01 | E I Du Pont De Nemours And Company | Pantothenic acid biosynthesis in zymomonas |
| US8911983B2 (en) * | 2011-12-20 | 2014-12-16 | E I Du Pont De Nemours And Company | Pnp gene modification for improved xylose utilization in Zymomonas |
| US20130157332A1 (en) | 2011-12-20 | 2013-06-20 | E I Du Pont De Nemours And Company | Gene inactivation allowing immediate growth on xylose medium by engineered zymomonas |
| CN102533769B (zh) * | 2012-02-28 | 2013-07-31 | 昆明理工大学 | 假单胞菌低温启动子及其应用 |
| US8697426B2 (en) | 2012-06-15 | 2014-04-15 | E I Du Pont De Nemours And Company | Contaminant control in Zymomonas fermentation using virginiamycin |
| US8759069B2 (en) | 2012-06-15 | 2014-06-24 | E I Du Pont De Nemours And Company | Contaminant control in Zymomonas fermentation using hop acids |
| US8846357B2 (en) | 2012-12-20 | 2014-09-30 | E I Du Pont De Nemours And Company | Stabilized chlorine dioxide for contamination control in Zymomonas fermentation |
| US20140273105A1 (en) | 2013-03-12 | 2014-09-18 | E I Du Pont De Nemours And Company | Gradient pretreatment of lignocellulosic biomass |
| US9139818B2 (en) * | 2013-09-26 | 2015-09-22 | E I Du Pont De Nemours And Company | High expression Zymomonas promoters |
| US20150087041A1 (en) | 2013-09-26 | 2015-03-26 | E I Du Pont De Nemours And Company | Production of ethanol with reduced contaminants in a cellulosic biomass based process |
| US20150087040A1 (en) | 2013-09-26 | 2015-03-26 | E I Du Pont De Nemours And Company | Production of ethanol and recycle water in a cellulosic fermentation process |
| US20150147786A1 (en) | 2013-11-24 | 2015-05-28 | E I Du Pont De Nemours And Company | High force and high stress destructuring for starch biomass processing |
| US9371546B2 (en) | 2014-06-24 | 2016-06-21 | E I Du Pont De Nemours And Company | Enhancing D-xylose and L-arabinose utilization in Zymomonas cells |
| WO2018106656A1 (en) | 2016-12-06 | 2018-06-14 | Danisco Us Inc | Truncated lpmo enzymes and use thereof |
| WO2019074828A1 (en) | 2017-10-09 | 2019-04-18 | Danisco Us Inc | CELLOBIOSE DEHYDROGENASE VARIANTS AND METHODS OF USE |
| CN114774421B (zh) * | 2022-05-07 | 2023-04-28 | 湖北大学 | 运动发酵单胞菌内源性启动子突变体 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004037973A2 (en) * | 2002-04-27 | 2004-05-06 | Midwest Research Institute | Zymomonas pentose-sugar fermentating strains and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5231020A (en) | 1989-03-30 | 1993-07-27 | Dna Plant Technology Corporation | Genetic engineering of novel plant phenotypes |
| AU2388295A (en) | 1994-04-15 | 1995-11-10 | Midwest Research Institute | Recombinant zymomonas for pentose fermentation |
| US5712133A (en) | 1994-04-15 | 1998-01-27 | Midwest Research Institute | Pentose fermentation by recombinant zymomonas |
| US5514583A (en) | 1994-04-15 | 1996-05-07 | Midwest Research Institute | Recombinant zymomonas for pentose fermentation |
| CN1283699A (zh) * | 1999-08-06 | 2001-02-14 | 中国科学院上海生物化学研究所 | 甲醇酵母表达系统中含有的多种启动子多表达盒 |
| US6566107B1 (en) | 2000-11-01 | 2003-05-20 | Midwest Research Institute | Recombinant Zymomonas mobilis with improved xylose utilization |
| US7259255B2 (en) * | 2003-06-25 | 2007-08-21 | E. I. Du Pont De Nemours And Company | Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase promoters for gene expression in oleaginous yeast |
| DE10359595A1 (de) * | 2003-12-18 | 2005-07-28 | Basf Ag | Pgro-Expressionseinheiten |
| AT501955B1 (de) * | 2005-02-23 | 2007-08-15 | Univ Graz Tech | Mutierte aox1-promotoren |
| RU2394913C2 (ru) | 2005-10-26 | 2010-07-20 | Е.И.Дюпон Де Немур Энд Компани | Ферментативное получение четырехуглеродных спиртов |
| JP2009521936A (ja) * | 2006-01-03 | 2009-06-11 | マサチューセッツ・インスティチュート・オブ・テクノロジー | プロモータ工学及び遺伝子制御 |
| US7741084B2 (en) | 2006-09-28 | 2010-06-22 | E. I. Du Pont De Nemours And Company | Ethanol production using xylitol synthesis mutant of xylose-utilizing zymomonas |
| US7741119B2 (en) | 2006-09-28 | 2010-06-22 | E. I. Du Pont De Nemours And Company | Xylitol synthesis mutant of xylose-utilizing zymomonas for ethanol production |
-
2009
- 2009-03-25 BR BRPI0906241A patent/BRPI0906241B8/pt not_active IP Right Cessation
- 2009-03-25 PL PL09725976T patent/PL2271755T3/pl unknown
- 2009-03-25 EP EP09725976.6A patent/EP2271755B1/en active Active
- 2009-03-25 WO PCT/US2009/038158 patent/WO2009120730A2/en not_active Ceased
- 2009-03-25 JP JP2011501995A patent/JP5444323B2/ja not_active Expired - Fee Related
- 2009-03-25 CN CN2009801106369A patent/CN101981184B/zh not_active Expired - Fee Related
- 2009-03-25 US US12/410,495 patent/US7989206B2/en active Active
- 2009-03-25 ES ES09725976.6T patent/ES2627671T3/es active Active
- 2009-03-25 AU AU2009228322A patent/AU2009228322B2/en not_active Ceased
- 2009-03-25 CA CA2716590A patent/CA2716590C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004037973A2 (en) * | 2002-04-27 | 2004-05-06 | Midwest Research Institute | Zymomonas pentose-sugar fermentating strains and uses thereof |
Non-Patent Citations (1)
| Title |
|---|
| Conway T et al, JOURNAL OF BACTERIOLOGY, 1987, 169(12):5653-5662 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101981184B (zh) | 2013-05-01 |
| BRPI0906241B8 (pt) | 2019-02-19 |
| EP2271755B1 (en) | 2017-03-22 |
| AU2009228322A1 (en) | 2009-10-01 |
| WO2009120730A3 (en) | 2009-12-10 |
| JP5444323B2 (ja) | 2014-03-19 |
| ES2627671T3 (es) | 2017-07-31 |
| BRPI0906241B1 (pt) | 2019-01-29 |
| EP2271755A2 (en) | 2011-01-12 |
| PL2271755T3 (pl) | 2017-08-31 |
| JP2011515106A (ja) | 2011-05-19 |
| CA2716590C (en) | 2016-05-17 |
| US7989206B2 (en) | 2011-08-02 |
| CN101981184A (zh) | 2011-02-23 |
| CA2716590A1 (en) | 2009-10-01 |
| US20090246876A1 (en) | 2009-10-01 |
| WO2009120730A2 (en) | 2009-10-01 |
| BRPI0906241A2 (pt) | 2015-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2009228322B2 (en) | High expression Zymomonas promoters | |
| AU2009228323B2 (en) | Zymomonas with improved xylose utilization | |
| ES2385857T3 (es) | Zymomonas con producción aumentada de etanol en medio que contiene azúcares concentrados y acetato | |
| ES2361385T3 (es) | Proceso para la producción de etanol en un medio que comprende xilosa que emplea una cepa de zymomonas recombinante con expresión de hima reducida. | |
| US9139818B2 (en) | High expression Zymomonas promoters | |
| CN103998607B (zh) | 用于改善发酵单胞菌属(Zymomonas)中的木糖利用率的PNP基因修饰 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |